# Transcend Auto vs Commercially Available Device Clinical Evaluation for Treatment of Obstructive Sleep Apnea (OSA)

> **NCT01799265** · NA · COMPLETED · sponsor: **Somnetics International, Inc.** · enrollment: 41 (actual)

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DEVICE:** Somnetics Transcend Auto
- **DEVICE:** Respironics REMstar Auto with C-Flex

## Key facts

- **NCT ID:** NCT01799265
- **Lead sponsor:** Somnetics International, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02-27
- **Primary completion:** 2013-06-10
- **Final completion:** 2013-06-10
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2025-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01799265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01799265, "Transcend Auto vs Commercially Available Device Clinical Evaluation for Treatment of Obstructive Sleep Apnea (OSA)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01799265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*